DE1015046T1 - Mikrodispersions-verabreichungssystem für arzneimittel - Google Patents

Mikrodispersions-verabreichungssystem für arzneimittel

Info

Publication number
DE1015046T1
DE1015046T1 DE1015046T DE99933952T DE1015046T1 DE 1015046 T1 DE1015046 T1 DE 1015046T1 DE 1015046 T DE1015046 T DE 1015046T DE 99933952 T DE99933952 T DE 99933952T DE 1015046 T1 DE1015046 T1 DE 1015046T1
Authority
DE
Germany
Prior art keywords
microdispersion
administration system
medicinal products
medicinal
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE1015046T
Other languages
English (en)
Inventor
Narayan Tallavajhala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EMD Chemicals Inc
EM Ind Inc
Original Assignee
EMD Chemicals Inc
EM Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EMD Chemicals Inc, EM Ind Inc filed Critical EMD Chemicals Inc
Publication of DE1015046T1 publication Critical patent/DE1015046T1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE1015046T 1998-07-14 1999-07-14 Mikrodispersions-verabreichungssystem für arzneimittel Pending DE1015046T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9276798P 1998-07-14 1998-07-14
PCT/US1999/015781 WO2000003753A2 (en) 1998-07-14 1999-07-14 Microdisperse drug delivery systems

Publications (1)

Publication Number Publication Date
DE1015046T1 true DE1015046T1 (de) 2001-02-08

Family

ID=22235064

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1015046T Pending DE1015046T1 (de) 1998-07-14 1999-07-14 Mikrodispersions-verabreichungssystem für arzneimittel

Country Status (8)

Country Link
EP (1) EP1015046A2 (de)
JP (1) JP2002520377A (de)
CN (1) CN1273526A (de)
AU (1) AU4989299A (de)
CA (1) CA2302735A1 (de)
DE (1) DE1015046T1 (de)
WO (1) WO2000003753A2 (de)
ZA (1) ZA200001010B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
JP2004536026A (ja) 2000-11-28 2004-12-02 トランスフォーム ファーマシューティカルズ，インコーポレーティッド． パクリタキセル、その誘導体、および薬剤として許容される塩を含む医薬品製剤
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
AU2002357012A1 (en) * 2001-11-27 2003-06-10 Transform Pharmaceuticals, Inc. Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine
EP1498122A1 (de) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Halbfeste Systeme enthaltend Azetidin-Derivate
EP1498143A1 (de) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Selbstemulgierende und selbstmicroemulgierende Formulierungen zur oralen Verabreichung von Taxoiden
EP1713442A1 (de) * 2004-01-30 2006-10-25 Pfizer Italia S.r.l. Halbfeste pharmazeutische matrixzubereitungen
US7659310B2 (en) 2004-04-27 2010-02-09 Formatech, Inc. Methods of enhancing solubility of agents
US7345093B2 (en) 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
FR2873585B1 (fr) * 2004-07-27 2006-11-17 Aventis Pharma Sa Nouvelles formulations galeniques de principes actifs
GB2451811A (en) 2007-08-09 2009-02-18 Ems Sa Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
EP2197426A2 (de) * 2007-10-19 2010-06-23 Abbott GmbH & Co. KG Eine verbindung auf n-aryl-harnstoff-basis enthaltendes festes dispersionsprodukt
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
US9402812B2 (en) 2009-09-23 2016-08-02 Indu JAVERI Methods for the preparation of liposomes
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565188A (en) * 1995-02-24 1996-10-15 Nanosystems L.L.C. Polyalkylene block copolymers as surface modifiers for nanoparticles

Also Published As

Publication number Publication date
CN1273526A (zh) 2000-11-15
JP2002520377A (ja) 2002-07-09
AU4989299A (en) 2000-02-07
WO2000003753A2 (en) 2000-01-27
WO2000003753A3 (en) 2000-05-04
EP1015046A2 (de) 2000-07-05
ZA200001010B (en) 2000-10-16
CA2302735A1 (en) 2000-01-27

Similar Documents

Publication Publication Date Title
DE1015046T1 (de) Mikrodispersions-verabreichungssystem für arzneimittel
EE200000546A (et) Aerosoolistatud toimeaine manustamissüsteem
ATE238773T1 (de) Arzneimittel für die kombination piperidinoalkanol-dekongestivum
DE69635993D1 (de) Gelierte arzneimittel zur oralen verabreichung
NO20014035D0 (no) System for oral administrasjon av medikament
DE69531788D1 (de) Verbessertes bioadhäsives pharmazeutisches abgabesystem
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
NO961136D0 (no) Farmasöytisk formuleringsgrunnlag for nano-suspensjoner
NO974618D0 (no) Farmasöytiske preparater for intranasal administrasjon
NO973630D0 (no) System for regulert avgivelse av medikament
DZ1876A1 (fr) Médicaments pour administration orale.
DE69908021T2 (de) Ziprasidonhaltige Arzneimittel
DE69935681D1 (de) Vorrichtungen zur Medikamentverabreichung
EP1416920A4 (de) MULTIPLEXES, FüR DIE ORALE VERBABREICHUNG GEEIGNETES MEDIKAMENTENABGABESYSTEM
ATE202472T1 (de) Arzneimittel enthaltend oxaliplatin
NO20012047L (no) Medikamentavleveringssystem, spesielt for avlevering av progestiner og östrogener
DE69711045T2 (de) Vitamin c abgabesystem
DE60019949D1 (de) Arzneimittel enthaltendes system zur oralen abgabevorrichtung
PT1153626E (pt) Aparelho de administracao de medicamentos
NO20005218D0 (no) Farmasøytisk aerosolpreparat
ATE367150T1 (de) Arzneimittel
ATE255909T1 (de) Konservierungssystem für topisch verabreichbare pharmazeutische zusammensetzungen
EP1061987A4 (de) Vorrichtung zum verabreichen eines medikamentes
IL109539A0 (en) Substained-release pharmaceutical system for the delivery of antioxidants
DK0868911T3 (da) Rapamycinpræparater til oral indgivelse